Healthpeak Properties (NYSE:DOC) Stock Unloaded Rep. Robert Bresnahan, Jr.

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Healthpeak Properties, Inc. NYSE: DOC. In a filing disclosed on June 09th, the Representative disclosed that they had sold between $1,001 and $15,000 in Healthpeak Properties stock on May 15th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Zoom Communications NASDAQ: ZM on 6/25/2025.
• Purchased $1,001 - $15,000 in shares of Coinbase Global NASDAQ: COIN on 6/24/2025.
• Purchased $1,001 - $15,000 in shares of Circle Internet Group NYSE: CRCL on 6/24/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 6/23/2025.
• Sold $1,001 - $15,000 in shares of Chubb NYSE: CB on 6/13/2025.
• Sold $1,001 - $15,000 in shares of Atlassian NASDAQ: TEAM on 6/11/2025.
• Purchased $1,001 - $15,000 in shares of ServiceTitan NASDAQ: TTAN on 6/11/2025.
• Sold $1,001 - $15,000 in shares of Datadog NASDAQ: DDOG on 6/11/2025.
• Sold $1,001 - $15,000 in shares of GitLab NASDAQ: GTLB on 6/11/2025.
• Purchased $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 6/11/2025.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC traded down $1.24 during mid-day trading on Friday, reaching $17.64. The company had a trading volume of 16,243,151 shares, compared to its average volume of 5,871,287. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.01. The firm has a market cap of $12.25 billion, a price-to-earnings ratio of 73.48, a PEG ratio of 2.15 and a beta of 1.03. The company's 50-day moving average price is $17.69 and its 200-day moving average price is $18.85. Healthpeak Properties, Inc. has a one year low of $16.64 and a one year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.83%. The company had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. During the same quarter in the previous year, the firm posted $0.45 earnings per share. The company's quarterly revenue was down .2% compared to the same quarter last year. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Friday, September 19th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.92%. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.

Insider Activity at Healthpeak Properties

In other news, Director John T. Thomas purchased 4,200 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was bought at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the acquisition, the director directly owned 813,566 shares of the company's stock, valued at $14,514,017.44. This represents a 0.52% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Tommy G. Thompson acquired 5,777 shares of the firm's stock in a transaction on Wednesday, May 28th. The stock was bought at an average price of $17.27 per share, with a total value of $99,768.79. Following the completion of the acquisition, the director directly owned 144,290 shares in the company, valued at approximately $2,491,888.30. This represents a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders bought 29,764 shares of company stock worth $521,909 in the last three months. 0.23% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Robert W. Baird reduced their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Argus reaffirmed a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Wedbush reduced their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Scotiabank cut their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. Finally, Evercore ISI cut their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $23.27.

Institutional Investors Weigh In On Healthpeak Properties

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. NorthRock Partners LLC raised its holdings in Healthpeak Properties by 25.8% during the 2nd quarter. NorthRock Partners LLC now owns 14,556 shares of the real estate investment trust's stock valued at $255,000 after buying an additional 2,981 shares during the last quarter. Verdence Capital Advisors LLC raised its holdings in Healthpeak Properties by 4.3% during the 2nd quarter. Verdence Capital Advisors LLC now owns 28,211 shares of the real estate investment trust's stock valued at $494,000 after buying an additional 1,176 shares during the last quarter. Sequoia Financial Advisors LLC raised its holdings in Healthpeak Properties by 55.7% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 138,808 shares of the real estate investment trust's stock valued at $2,431,000 after buying an additional 49,650 shares during the last quarter. LRI Investments LLC raised its holdings in Healthpeak Properties by 18.4% during the 2nd quarter. LRI Investments LLC now owns 4,481 shares of the real estate investment trust's stock valued at $78,000 after buying an additional 697 shares during the last quarter. Finally, Concurrent Investment Advisors LLC raised its holdings in Healthpeak Properties by 148.5% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 27,879 shares of the real estate investment trust's stock valued at $488,000 after buying an additional 16,661 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.